No quarterly revenue total was found in CalciMedica, Inc.'s SEC filings.
CalciMedica, Inc. (CALC) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$4.6 million.
Revenue
—
Net income
$-7.65M
-28.5% vs year-ago quarter
Operating cash flow
$-4.62M
+30.7% vs year-ago quarter
Free cash flow
$-4.62M
+30.8% vs year-ago quarter
EPS
$-0.45
-12.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
34.14M
+144.4% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CALC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534133
- Former names
- CalciMedica, Inc. /DE/ (until Mar 22, 2023); GRAYBUG VISION, INC. (until Mar 15, 2023); GRAYBUG, Inc. (until May 13, 2016); GRAYBUG LLC (until Oct 7, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$4.0M | -$5.6M | -$4.4M | -$5.6M | -$6.6M |
| Net income | -$7.7M | $5.0M | -$10.8M | -$7.8M | -$6.0M |
| Diluted EPS | -$0.45 | $0.30 | -$0.68 | -$0.52 | -$0.40 |
| Operating cash flow | -$4.6M | -$4.9M | -$4.9M | -$4.8M | -$6.7M |
| Free cash flow | -$4.6M | -$4.9M | -$4.9M | -$4.8M | -$6.7M |
| Total assets | $19.5M | $8.6M | $13.6M | $14.9M | $19.1M |
| Total liabilities | $14.0M | $9.7M | $20.2M | $15.2M | $13.0M |
| Stockholders' equity | $5.5M | -$1.1M | -$6.6M | -$268,000 | $6.1M |
| Cash and investments | $18.6M | $8.2M | $13.0M | $14.1M | $18.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 20, 2026 | Aug 19, 2026 |
All 531 CalciMedica, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.